08 Apr 2016
The Optometry Board of Australia (the Board) has released its report for 2014/15.
During 2014/15 the Board revised its guidelines for the use of scheduled medicines which were published in December 2014 (these were a revised version of guidelines published in 2013). These guidelines enable optometrists to diagnose, initiate, treat and monitor chronic glaucoma patients. The revised guidelines enhance the early diagnosis and treatment of chronic glaucoma in the best interest of the public, and clarify the timelines for information exchange between treating optometrists and ophthalmologists.
The Board’s registration standard for general registration for initial applicants came into effect on 1 December 2014, which acknowledges that the current undergraduates from Board approved programs leading to general registration incorporates ocular therapeutics as part of their undergraduate degree and enables those graduates to be automatically eligible for the scheduled medicines endorsement upon application for registration.
Download a copy of the report below:
Optometry regulation at work in Australia - 2014/15 (37.5 KB,PDF),Word version (40.7 KB,DOCX)